Loading...

Darius Lakdawalla, PhD

Title(s)Professor Of Pharmaceutical Economics And Public Policy And Quintiles Chair In Pharmaceutical And Regulatory Innovation
Phone+1 213 538 8736
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Darius Lakdawalla is a Professor in the University of Southern California (USC) School of Pharmacy and in the Sol Price School of Public Policy, and holds the Quintiles Chair in Pharmaceutical Development and Regulatory Innovation. Dr. Lakdawalla is also Director of Research at the Leonard D. Schaeffer Center for Health Policy and Economics at USC.

    He has been the recipient of the Milken Institute’s Distinguished Economic Research Award for best research in the field of economics, and the recipient of the Garfield Prize for research on the economics of medical innovation. His work has been published in leading journals of economics, medicine, and health policy, and funded by the National Institute of Aging, the National Institute of Child Health and Human Development, and the National Bureau of Economic Research.

    Dr. Lakdawalla is currently a Research Associate in the Health Care and Health Economics programs at the National Bureau of Economic Research, in Cambridge, Mass., and a Visiting Scholar at the American Enterprise Institute. He serves as an Associate Editor at the Review of Economics and Statistics. He is also the former Director of Research at the Bing Center for Health Economics at the RAND Corporation.

    Dr. Lakdawalla received his BS in mathematics and philosophy from Amherst College and his PhD in economics from the University of Chicago.

    Collapse Research 
    Collapse Research Activities and Funding
    Ensuring Access to Novel Alzheimer?s and Dementia Treatments: Evaluating Innovative Payment Approaches
    NIH/NIA R01AG062277Sep 30, 2018 - May 31, 2022
    Role: Co-Principal Investigator
    Medical Malpractice, Health Care Costs, and Technology Adoption
    NIH/NIA R01AG031544Jun 1, 2009 - May 31, 2014
    Role: Principal Investigator
    EFFECT OF MEDICAL MALPRACTICE ON COSTS &TECH ADOPTION
    NIH/NIA R03AG025809Jun 1, 2005 - May 31, 2008
    Role: Principal Investigator
    WHOM DOES MEDICARE BENEFIT
    NIH/NIA R01AG021940Aug 15, 2004 - Jan 31, 2009
    Role: Principal Investigator
    Unclaimed Injuries and Workers' Compensation Adequacy
    CDC/NIOSH R03OH007619Sep 1, 2002 - Aug 31, 2005
    Role: Principal Investigator
    The Redistributive Effects of Medicare
    NIH/NIA R03AG020266Sep 30, 2001 - Sep 29, 2003
    Role: Principal Investigator
    Age Difference of Spouses and Long-Term Care
    NIH/NIA R03AG019900Sep 15, 2001 - Aug 31, 2003
    Role: Principal Investigator
    RAND MiniMedical School for Social Scientists
    NIH/NIA R13AG018327Sep 15, 2000 - Dec 31, 2023
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, Brauer M, Baldassano RN. Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis. Clin Gastroenterol Hepatol. 2019 Jul 18. PMID: 31326606.
      View in: PubMed
    2. MacEwan JP, Doctor J, Mulligan K, May SG, Batt K, Zacker C, Lakdawalla D, Goldman D. The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers. MDM Policy Pract. 2019 Jan-Jun; 4(1):2381468319855386. PMID: 31259249.
      View in: PubMed
    3. Sussell J, Vanderpuye-Orgle J, Vania D, Goertz HP, Lakdawalla D. Understanding price growth in the market for targeted oncology therapies. Am J Manag Care. 2019 Jun; 25(6):273-277. PMID: 31211554.
      View in: PubMed
    4. Shafrin J, Silverstein AR, MacEwan JP, Lakdawalla DN, Hatch A, Forma FM. Using Information on Patient Adherence to Antipsychotic Medication to Understand Their Adherence to Other Medications. P T. 2019 Jun; 44(6):350-357. PMID: 31160870.
      View in: PubMed
    5. Incerti D, Curtis JR, Shafrin J, Lakdawalla DN, Jansen JP. A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis. Pharmacoeconomics. 2019 Jun; 37(6):829-843. PMID: 30737711.
      View in: PubMed
    6. Jena AB, Snider JT, Diaz Espinosa O, Ingram A, Sanchez Gonzalez Y, Lakdawalla D. How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom? Value Health. 2019 Jun; 22(6):669-676. PMID: 31198184.
      View in: PubMed
    7. Chen A, Lakdawalla DN. Healing the poor: The influence of patient socioeconomic status on physician supply responses. J Health Econ. 2019 Mar; 64:43-54. PMID: 30797112.
      View in: PubMed
    8. Baumgardner J, Shahabi A, Zacker C, Lakdawalla D. Cost variation and savings opportunities in the Oncology Care Model. Am J Manag Care. 2018 Dec; 24(12):618-623. PMID: 30586495.
      View in: PubMed
    9. Baumgardner JR, Shahabi A, Linthicum MT, Zacker C, Lakdawalla DN. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model. J Oncol Pract. 2018 Nov; 14(11):e699-e710. PMID: 30423271.
      View in: PubMed
    10. Jena AB, Chou JW, Yoon L, Aubry WM, Berger J, Burton W, Fendrick AM, Fick DM, Franklin D, Killion R, Lakdawalla DN, Neumann PJ, Patel K, Yee J, Sakurada B, Yu-Isenberg K. Understanding and improving value frameworks with real-world patient outcomes. Am J Manag Care. 2018 Nov; 24(11):506-509. PMID: 30452207.
      View in: PubMed
    11. Shafrin J, Bognar K, Everson K, Brauer M, Lakdawalla DN, Forma FM. Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness. Clinicoecon Outcomes Res. 2018; 10:573-585. PMID: 30323635.
      View in: PubMed
    12. Baumgardner J, Shahabi A, Linthicum M, Vine S, Zacker C, Lakdawalla D. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes. J Manag Care Spec Pharm. 2018 Jun; 24(6):504-513. PMID: 29799330.
      View in: PubMed
    13. MacEwan JP, Silverstein AR, Shafrin J, Lakdawalla DN, Hatch A, Forma FM. Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical Illnesses. Adv Ther. 2018 May; 35(5):671-685. PMID: 29725982.
      View in: PubMed
    14. Lakdawalla DN, Doshi JA, Garrison LP, Phelps CE, Basu A, Danzon PM. Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]. Value Health. 2018 02; 21(2):131-139. PMID: 29477390.
      View in: PubMed
    15. Phelps CE, Lakdawalla DN, Basu A, Drummond MF, Towse A, Danzon PM. Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5]. Value Health. 2018 02; 21(2):146-154. PMID: 29477392.
      View in: PubMed
    16. Garrison LP, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]. Value Health. 2018 02; 21(2):161-165. PMID: 29477394.
      View in: PubMed
    17. Sachs R, Bagley N, Lakdawalla DN. Innovative Contracting for Pharmaceuticals and Medicaid's Best-Price Rule. J Health Polit Policy Law. 2018 02 01; 43(1):5-18. PMID: 28972020.
      View in: PubMed
    18. Jena AB, Zhang J, Lakdawalla DN. The Trade-off Between Speed and Safety in Drug Approvals. JAMA Oncol. 2017 11 01; 3(11):1465-1466. PMID: 27684643.
      View in: PubMed
    19. Lakdawalla D, MacEwan JP, Dubois R, Westrich K, Berdud M, Towse A. What do pharmaceuticals really cost in the long run? Am J Manag Care. 2017 Aug; 23(8):488-493. PMID: 29087143.
      View in: PubMed
    20. Shafrin J, May SG, Shrestha A, Ruetsch C, Gerlanc N, Forma F, Hatch A, Lakdawalla DN, Lindenmayer JP. Access to credible information on schizophrenia patients' medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers. Patient Prefer Adherence. 2017; 11:1071-1081. PMID: 28721020.
      View in: PubMed
    21. Shrestha A, Eldar-Lissai A, Hou N, Lakdawalla DN, Batt K. Real-world resource use and costs of haemophilia A-related bleeding. Haemophilia. 2017 Jul; 23(4):e267-e275. PMID: 28574162.
      View in: PubMed
    22. Lakdawalla DN, Shafrin J, Hou N, Peneva D, Vine S, Park J, Zhang J, Brookmeyer R, Figlin RA. Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework. Value Health. 2017 Jul - Aug; 20(7):866-875. PMID: 28712615.
      View in: PubMed
    23. Shafrin J, Forma F, Scherer E, Hatch A, Vytlacil E, Lakdawalla D. The cost of adherence mismeasurement in serious mental illness: a claims-based analysis. Am J Manag Care. 2017 May 01; 23(5):e156-e163. PMID: 28810130.
      View in: PubMed
    24. Bognar K, Romley JA, Bae JP, Murray J, Chou JW, Lakdawalla DN. The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions. J Health Econ. 2017 01; 51:1-12. PMID: 27992772.
      View in: PubMed
    25. MacEwan JP, Forma FM, Shafrin J, Hatch A, Lakdawalla DN, Lindenmayer JP. Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia. J Manag Care Spec Pharm. 2016 Nov; 22(11):1349-1361. PMID: 27783548.
      View in: PubMed
    26. Shafrin J, Schwartz TT, Lakdawalla DN, Forma FM. Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia. J Manag Care Spec Pharm. 2016 Nov; 22(11):1285-1291. PMID: 27783545.
      View in: PubMed
    27. Shih T, Wakeford C, Meletiche D, Sussell J, Chung A, Liu Y, Shim JJ, Lakdawalla D. Reconsidering the economic value of multiple sclerosis therapies. Am J Manag Care. 2016 Nov 01; 22(11):e368-e374. PMID: 27849348.
      View in: PubMed
    28. Seabury SA, Goldman DP, Gupta CN, Khan ZM, Chandra A, Philipson TJ, Lakdawalla DN. Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection. Forum Health Econ Policy. 2016 Jun 01; 19(1):141-156. PMID: 31419891.
      View in: PubMed
    29. Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, Lakdawalla DN. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res. 2016 05 10; 16:175. PMID: 27165638.
      View in: PubMed
    30. Lakdawalla DN, Linthicum MT, Vanderpuye-Orgle J. Does patient cost sharing for HCV drugs make sense? Am J Manag Care. 2016 May; 22(6 Spec No.):SP188-90. PMID: 27266947.
      View in: PubMed
    31. Jena AB, Stevens W, Gonzalez YS, Marx SE, Juday T, Lakdawalla DN, Philipson TJ. The wider public health value of HCV treatment accrued by liver transplant recipients. Am J Manag Care. 2016 May; 22(6 Spec No.):SP212-9. PMID: 27266951.
      View in: PubMed
    32. Linthicum MT, Gonzalez YS, Mulligan K, Moreno GA, Dreyfus D, Juday T, Marx SE, Lakdawalla DN, Edlin BR, Brookmeyer R. Value of expanding HCV screening and treatment policies in the United States. Am J Manag Care. 2016 May; 22(6 Spec No.):SP227-35. PMID: 27266953.
      View in: PubMed
    33. Moreno GA, Mulligan K, Huber C, Linthicum MT, Dreyfus D, Juday T, Marx SE, Gonzalez YS, Brookmeyer R, Lakdawalla DN. Costs and spillover effects of private insurers' coverage of hepatitis C treatment. Am J Manag Care. 2016 May; 22(6 Spec No.):SP236-44. PMID: 27266954.
      View in: PubMed
    34. Shafrin J, Brookmeyer R, Peneva D, Park J, Zhang J, Figlin RA, Lakdawalla DN. The value of surrogate endpoints for predicting real-world survival across five cancer types. Curr Med Res Opin. 2016; 32(4):731-9. PMID: 26743800.
      View in: PubMed
    35. Snider JT, Jena AB, Linthicum MT, Hegazi RA, Partridge JS, LaVallee C, Lakdawalla DN, Wischmeyer PE. Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. Chest. 2015 Jun; 147(6):1477-1484. PMID: 25357165.
      View in: PubMed
    36. Seabury SA, Lakdawalla DN, Dougherty JS, Sullivan J, Goldman DP. Medication adherence and measures of health plan quality. Am J Manag Care. 2015 Jun 01; 21(6):e379-89. PMID: 26247579.
      View in: PubMed
    37. Eber MR, Goldman DP, Lakdawalla DN, Philipson TJ, Pritchard D, Huesch M, Summers N, Linthicum MT, Sullivan J, Dubois RW. Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments. J Comp Eff Res. 2015 May; 4(3):203-213. PMID: 25951244.
      View in: PubMed
    38. Lakdawalla DN, Chou JW, Linthicum MT, MacEwan JP, Zhang J, Goldman DP. Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer. JAMA Oncol. 2015 May; 1(2):196-202. PMID: 26181023.
      View in: PubMed
    39. Lakdawalla D, Yin W. Insurers' Negotiating Leverage and the External Effects of Medicare Part D. Rev Econ Stat. 2015 May 01; 97(2):314-331. PMID: 25937676.
      View in: PubMed
    40. Lakdawalla D, Shafrin J, Lucarelli C, Nicholson S, Khan ZM, Philipson TJ. Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gains. Health Aff (Millwood). 2015 Apr; 34(4):555-61. PMID: 25847636.
      View in: PubMed
    41. Chou JW, Lakdawalla DN, Vanderpuye-Orgle J. Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets. Forum Health Econ Policy. 2015 Jan 01; 18(1):65-74. PMID: 31419883.
      View in: PubMed
    42. Romley JA, Axeen S, Lakdawalla DN, Chernew ME, Bhattacharya J, Goldman DP. The Relationship between Commercial Health Care Prices and Medicare Spending and Utilization. Health Serv Res. 2015 Jun; 50(3):883-96. PMID: 25429755.
      View in: PubMed
    43. Lakdawalla D, Thornton SJ, Perlroth D, LaVallee C, Linthicum MT, Philipson TJ, Partridge J, Wischmeyer P. Effect of Oral Nutritional Supplements On Hospital Outcomes in Patients Aged 65+ With Congestive Heart Failure. Value Health. 2014 Nov; 17(7):A503. PMID: 27201530.
      View in: PubMed
    44. Linthicum MT, Thornton Snider J, Vaithianathan R, Wu Y, LaVallee C, Lakdawalla DN, Benner JE, Philipson TJ. Economic burden of disease-associated malnutrition in China. Asia Pac J Public Health. 2015 May; 27(4):407-17. PMID: 25301845.
      View in: PubMed
    45. Snider JT, Linthicum MT, Wu Y, LaVallee C, Lakdawalla DN, Hegazi R, Matarese L. Economic burden of community-based disease-associated malnutrition in the United States. JPEN J Parenter Enteral Nutr. 2014 Nov; 38(2 Suppl):77S-85S. PMID: 25249028.
      View in: PubMed
    46. Lakdawalla DN, Mascarenhas M, Jena AB, Vanderpuye-Orgle J, LaVallee C, Linthicum MT, Snider JT. Impact of oral nutrition supplements on hospital outcomes in pediatric patients. JPEN J Parenter Enteral Nutr. 2014 Nov; 38(2 Suppl):42S-9S. PMID: 25233942.
      View in: PubMed
    47. Seabury SA, Lakdawalla DN, Walter D, Hayes J, Gustafson T, Shrestha A, Goldman DP. Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants. Forum Health Econ Policy. 2014 Sep 01; 17(2):153-168. PMID: 31419879.
      View in: PubMed
    48. Lakdawalla DN, Snider JT, Perlroth DJ, LaVallee C, Linthicum MT, Philipson TJ, Partridge JS, Wischmeyer PE. Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? Forum Health Econ Policy. 2014 Sep 01; 17(2):131-151. PMID: 31419880.
      View in: PubMed
    49. Gupta C, Chertow GM, Linthicum MT, Van Nuys K, Belozeroff V, Quarles D, Lakdawalla DN. Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism. Health Serv Res. 2014 Dec; 49(6):1925-43. PMID: 25040130.
      View in: PubMed
    50. Goldman D, Fastenau J, Dirani R, Helland E, Joyce G, Conrad R, Lakdawalla D. Medicaid prior authorization policies and imprisonment among patients with schizophrenia. Am J Manag Care. 2014 Jul; 20(7):577-86. PMID: 25295404.
      View in: PubMed
    51. Kaestner R, Darden M, Lakdawalla D. Are investments in disease prevention complements? The case of statins and health behaviors. J Health Econ. 2014 Jul; 36:151-63. PMID: 24814322.
      View in: PubMed
    52. Mangalmurti S, Seabury SA, Chandra A, Lakdawalla D, Oetgen WJ, Jena AB. Medical professional liability risk among US cardiologists. Am Heart J. 2014 May; 167(5):690-6. PMID: 24766979.
      View in: PubMed
    53. Seabury SA, Goldman DP, Kalsekar I, Sheehan JJ, Laubmeier K, Lakdawalla DN. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. Am J Manag Care. 2014 Feb 01; 20(2):e52-60. PMID: 24738555.
      View in: PubMed
    54. Lakdawalla DN, Jena AB, Doctor JN. Careful use of science to advance the debate on the UK Cancer Drugs Fund. JAMA. 2014 Jan 01; 311(1):25-6. PMID: 24381964.
      View in: PubMed
    55. Stevens W, Philipson T, Wu Y, Chen C, Lakdawalla D. A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies. Forum Health Econ Policy. 2014 Jan 01; 17(1):21-52. PMID: 31419878.
      View in: PubMed
    56. Lakdawalla D, Sood N, Gu Q. Pharmaceutical advertising and Medicare Part D. J Health Econ. 2013 Dec; 32(6):1356-67. PMID: 24308884.
      View in: PubMed
    57. Solomon MD, Vijan S, Forma FM, Conrad RM, Summers NT, Lakdawalla DN. The impact of insulin type on severe hypoglycaemia events requiring inpatient and emergency department care in patients with type 2 diabetes. Diabetes Res Clin Pract. 2013 Dec; 102(3):175-82. PMID: 24188928.
      View in: PubMed
    58. Goldman DP, Gupta C, Vasudeva E, Trakas K, Riley R, Lakdawalla D, Agus D, Sood N, Jena AB, Philipson TJ. The Value of Diagnostic Testing in Personalized Medicine. Forum Health Econ Policy. 2013 Sep 01; 16(2):S87-S99. PMID: 31419871.
      View in: PubMed
    59. Turakhia MP, Solomon MD, Jhaveri M, Davis P, Eber MR, Conrad R, Summers N, Lakdawalla D. Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation. Am Heart J. 2013 Sep; 166(3):573-80. PMID: 24016509.
      View in: PubMed
    60. Lakdawalla D, Sood N. Health Insurance as a Two-Part Pricing Contract. J Public Econ. 2013 Jun 01; 102:1-12. PMID: 23997354.
      View in: PubMed
    61. Lakdawalla D, Turakhia MP, Jhaveri M, Mozaffari E, Davis P, Bradley L, Solomon MD. Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation. J Comp Eff Res. 2013 May; 2(3):301-12. PMID: 24236629.
      View in: PubMed
    62. Lakdawalla D, Eber MR, Forma FM, Sullivan J, Michaud PC, Bradley LA, Goldman DP. Measuring the value of better diabetes management. Am J Manag Care. 2013 Mar-Apr; 19 Spec No. 2:E11. PMID: 23725237.
      View in: PubMed
    63. Chernew ME, McKellar R, Aubry W, Beck R, Benner J, Berger JE, Fendrick AM, Forma F, Goldman D, Peters Harmel A, Killion R, Lakdawalla D, Owens DK, Stahl J. Comparative effectiveness research and formulary placement: the case of diabetes. Am J Manag Care. 2013 Feb; 19(2):93-6. PMID: 23448106.
      View in: PubMed
    64. Philipson TJ, Snider JT, Lakdawalla DN, Stryckman B, Goldman DP. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care. 2013 Feb; 19(2):121-8. PMID: 23448109.
      View in: PubMed
    65. Seabury SA, Chandra A, Lakdawalla DN, Jena AB. On average, physicians spend nearly 11 percent of their 40-year careers with an open, unresolved malpractice claim. Health Aff (Millwood). 2013 Jan; 32(1):111-9. PMID: 23297278.
      View in: PubMed
    66. Lakdawalla DN, Seabury SA. The Welfare Effects of Medical Malpractice Liability. Int Rev Law Econ. 2012 Dec; 32(4):356-369. PMID: 23526860.
      View in: PubMed
    67. Huesch M, Lakdawalla D. Freedom to innovate: the perils of centralized medical research. Arch Intern Med. 2012 Nov 26; 172(21):1692-3; author reply 1693. PMID: 23183865.
      View in: PubMed
    68. Darkow T, Maclean R, Joyce GF, Goldman D, Lakdawalla DN. Coverage and use of cancer therapies in the treatment of chronic myeloid leukemia. Am J Manag Care. 2012 Nov; 18(11 Suppl):S272-8. PMID: 23327459.
      View in: PubMed
    69. Yin W, Penrod JR, Maclean R, Lakdawalla DN, Philipson T. Value of survival gains in chronic myeloid leukemia. Am J Manag Care. 2012 Nov; 18(11 Suppl):S257-64. PMID: 23327457.
      View in: PubMed
    70. Grabowski DC, Lakdawalla DN, Goldman DP, Eber M, Liu LZ, Abdelgawad T, Kuznik A, Chernew ME, Philipson T. The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood). 2012 Oct; 31(10):2276-85. PMID: 23048109.
      View in: PubMed
    71. Jena AB, Chandra A, Lakdawalla D, Seabury S. Outcomes of medical malpractice litigation against US physicians. Arch Intern Med. 2012 Jun 11; 172(11):892-4. PMID: 22825616.
      View in: PubMed
    72. Michaud PC, Goldman DP, Lakdawalla DN, Zheng Y, Gailey AH. The value of medical and pharmaceutical interventions for reducing obesity. J Health Econ. 2012 Jul; 31(4):630-43. PMID: 22705389.
      View in: PubMed
    73. Seabury S, Chandra A, Lakdawalla D, Jena AB. Defense costs of medical malpractice claims. N Engl J Med. 2012 Apr 05; 366(14):1354-6. PMID: 22475613.
      View in: PubMed
    74. Philipson T, Eber M, Lakdawalla DN, Corral M, Conti R, Goldman DP. An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood). 2012 Apr; 31(4):667-75. PMID: 22492882.
      View in: PubMed
    75. Seabury SA, Goldman DP, Maclean JR, Penrod JR, Lakdawalla DN. Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood). 2012 Apr; 31(4):691-9. PMID: 22492885.
      View in: PubMed
    76. Lakdawalla DN, Romley JA, Sanchez Y, Maclean JR, Penrod JR, Philipson T. How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies. Health Aff (Millwood). 2012 Apr; 31(4):676-82. PMID: 22492883.
      View in: PubMed
    77. Lakdawalla D, Philipson T. Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets. J Law Econ. 2012 Feb 01; 55(1):151-187. PMID: 25221349.
      View in: PubMed
    78. Faulkner GE, Grootendorst P, Nguyen VH, Andreyeva T, Arbour-Nicitopoulos K, Auld MC, Cash SB, Cawley J, Donnelly P, Drewnowski A, Dubé L, Ferrence R, Janssen I, Lafrance J, Lakdawalla D, Mendelsen R, Powell LM, Traill WB, Windmeijer F. Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey. Int J Behav Nutr Phys Act. 2011 Oct 06; 8:109. PMID: 21978599.
      View in: PubMed
    79. Jena AB, Seabury S, Lakdawalla D, Chandra A. Malpractice risk according to physician specialty. N Engl J Med. 2011 Aug 18; 365(7):629-36. PMID: 21848463.
      View in: PubMed
    80. Michaud PC, Goldman D, Lakdawalla D, Gailey A, Zheng Y. Differences in health between Americans and Western Europeans: Effects on longevity and public finance. Soc Sci Med. 2011 Jul; 73(2):254-63. PMID: 21719178.
      View in: PubMed
    81. Goldman DP, Lakdawalla DN, Malkin JD, Romley J, Philipson T. The benefits from giving makers of conventional 'small molecule' drugs longer exclusivity over clinical trial data. Health Aff (Millwood). 2011 Jan; 30(1):84-90. PMID: 21209443.
      View in: PubMed
    82. Goldman D, Lakdawalla D, Philipson TJ, Yin W. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA. Health Econ. 2010 Oct; 19(10):1109-16. PMID: 20842680.
      View in: PubMed
    83. Jena AB, Goldman DP, Kamdar A, Lakdawalla DN, Lu Y. Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med. 2010 Jul 06; 153(1):1-7. PMID: 20621899.
      View in: PubMed
    84. Chen E, Looman M, Laouri M, Gallagher M, Van Nuys K, Lakdawalla D, Fortuny J. Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin. 2010 Jul; 26(7):1587-97. PMID: 20429823.
      View in: PubMed
    85. Lakdawalla DN, Sun EC, Jena AB, Reyes CM, Goldman DP, Philipson TJ. An economic evaluation of the war on cancer. J Health Econ. 2010 May; 29(3):333-46. PMID: 20363520.
      View in: PubMed
    86. Gailey A, Lakdawalla D, Sood N. Patents, innovation, and the welfare effects of Medicare Part D. Adv Health Econ Health Serv Res. 2010; 22:317-44. PMID: 20575239.
      View in: PubMed
    87. Goldman DP, Jena AB, Lakdawalla DN, Malin JL, Malkin JD, Sun E. The value of specialty oncology drugs. Health Serv Res. 2010 Feb; 45(1):115-32. PMID: 19878344.
      View in: PubMed
    88. Lakdawalla D, Philipson T. The growth of obesity and technological change. Econ Hum Biol. 2009 Dec; 7(3):283-93. PMID: 19748839.
      View in: PubMed
    89. Lakdawalla D, Sood N. Innovation and The Welfare Effects of Public Drug Insurance. J Public Econ. 2009 Apr 01; 93(3-4):541-548. PMID: 20454467.
      View in: PubMed
    90. Stewart KA, Grabowski DC, Lakdawalla DN. Annual expenditures for nursing home care: private and public payer price growth, 1977 to 2004. Med Care. 2009 Mar; 47(3):295-301. PMID: 19194339.
      View in: PubMed
    91. Sood N, de Vries H, Gutierrez I, Lakdawalla DN, Goldman DP. The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff (Millwood). 2009 Jan-Feb; 28(1):w125-37. PMID: 19088100.
      View in: PubMed
    92. Lakdawalla DN, Goldman DP, Michaud PC, Sood N, Lempert R, Cong Z, de Vries H, Gutierrez I. U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood). 2009 Jan-Feb; 28(1):w138-50. PMID: 19088101.
      View in: PubMed
    93. Bhattacharya J, Choudhry K, Lakdawalla D. Chronic disease and severe disability among working-age populations. Med Care. 2008 Jan; 46(1):92-100. PMID: 18162861.
      View in: PubMed
    94. Lakdawalla D, Philipson T, Bhattacharya J. Welfare-Enhancing Technological Change and the Growth of Obesity. Am Econ Rev. 2005 May; 95(2):253-7. PMID: 29125263.
      View in: PubMed
    95. Lakdawalla DN, Goldman DP, Shang B. The health and cost consequences of obesity among the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R30-41. PMID: 16186149.
      View in: PubMed
    96. Goldman DP, Shang B, Bhattacharya J, Garber AM, Hurd M, Joyce GF, Lakdawalla DN, Panis C, Shekelle PG. Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R5-17. PMID: 16186147.
      View in: PubMed
    97. Bhattacharya J, Cutler DM, Goldman DP, Hurd MD, Joyce GF, Lakdawalla DN, Panis CW, Shang B. Disability forecasts and future Medicare costs. Front Health Policy Res. 2004; 7:75-94. PMID: 15612336.
      View in: PubMed
    98. Lakdawalla DN, Bhattacharya J, Goldman DP. Are the young becoming more disabled? Health Aff (Millwood). 2004 Jan-Feb; 23(1):168-76. PMID: 15002639.
      View in: PubMed
    99. Lakdawalla D, Bhattacharya J, Goldman DP. A response to the points by Manton and Williamson. Med Care. 2003 Jan; 41(1):28-31. PMID: 12544541.
      View in: PubMed
    100. Lakdawalla D, Goldman DP, Bhattacharya J, Hurd MD, Joyce GF, Panis CW. Forecasting the nursing home population. Med Care. 2003 Jan; 41(1):8-20. PMID: 12544538.
      View in: PubMed
    101. Goldman DP, Lakdawalla D. A new method for determining patient payments for outpatient drugs. Am J Manag Care. 2002 Feb; 8(2):125, 128, 130. PMID: 11853200.
      View in: PubMed
    102. Lakdawalla D, Philipson T. The Rise in Old-Age Longevity and the Market for Long-Term Care. Am Econ Rev. 2002; 92(1):295-306. PMID: 29058393.
      View in: PubMed